Geode Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,460,684
Closed -$18M 4550
2024
Q4
$18M Sell
1,460,684
-5,471
-0.4% -$67.6K ﹤0.01% 2020
2024
Q3
$16.7M Buy
1,466,155
+34,328
+2% +$391K ﹤0.01% 2075
2024
Q2
$10.2M Buy
1,431,827
+41,886
+3% +$299K ﹤0.01% 2314
2024
Q1
$9.31M Buy
1,389,941
+42,766
+3% +$287K ﹤0.01% 2370
2023
Q4
$8.76M Buy
1,347,175
+65,439
+5% +$425K ﹤0.01% 2415
2023
Q3
$12.1M Buy
1,281,736
+18,263
+1% +$172K ﹤0.01% 2138
2023
Q2
$17.7M Buy
1,263,473
+51,546
+4% +$720K ﹤0.01% 1937
2023
Q1
$22.7M Buy
1,211,927
+56,401
+5% +$1.06M ﹤0.01% 1712
2022
Q4
$15.9M Buy
1,155,526
+39,812
+4% +$548K ﹤0.01% 1926
2022
Q3
$21.3M Buy
1,115,714
+6,955
+0.6% +$133K ﹤0.01% 1683
2022
Q2
$16.9M Buy
1,108,759
+7,974
+0.7% +$122K ﹤0.01% 1872
2022
Q1
$22.4M Sell
1,100,785
-2,610
-0.2% -$53.2K ﹤0.01% 1814
2021
Q4
$32.2M Buy
1,103,395
+103,147
+10% +$3.01M ﹤0.01% 1641
2021
Q3
$21.6M Buy
1,000,248
+7,561
+0.8% +$163K ﹤0.01% 1908
2021
Q2
$25.5M Buy
992,687
+53,821
+6% +$1.38M ﹤0.01% 1801
2021
Q1
$17.1M Buy
938,866
+126,008
+16% +$2.3M ﹤0.01% 1973
2020
Q4
$9.38M Buy
812,858
+43,073
+6% +$497K ﹤0.01% 2225
2020
Q3
$5.87M Buy
769,785
+10,657
+1% +$81.2K ﹤0.01% 2299
2020
Q2
$4.98M Buy
759,128
+18,439
+2% +$121K ﹤0.01% 2342
2020
Q1
$3.78M Buy
740,689
+42,493
+6% +$217K ﹤0.01% 2296
2019
Q4
$5.36M Sell
698,196
-29,676
-4% -$228K ﹤0.01% 2411
2019
Q3
$3.86M Buy
727,872
+36,579
+5% +$194K ﹤0.01% 2539
2019
Q2
$3.87M Buy
691,293
+98,201
+17% +$550K ﹤0.01% 2548
2019
Q1
$2.52M Buy
593,092
+65,320
+12% +$278K ﹤0.01% 2712
2018
Q4
$2.16M Buy
527,772
+27,685
+6% +$113K ﹤0.01% 2730
2018
Q3
$3.43M Buy
500,087
+33,444
+7% +$229K ﹤0.01% 2598
2018
Q2
$1.83M Buy
466,643
+240,967
+107% +$944K ﹤0.01% 2906
2018
Q1
$658K Sell
225,676
-225,676
-50% -$658K ﹤0.01% 3302
2017
Q4
$1.75M Buy
451,352
+225,676
+100% +$875K ﹤0.01% 2830
2017
Q3
$709K Buy
225,676
+1
+0% +$3 ﹤0.01% 3244
2017
Q2
$960K Buy
225,675
+20,319
+10% +$86.4K ﹤0.01% 3122
2017
Q1
$940K Buy
205,356
+49,259
+32% +$225K ﹤0.01% 3047
2016
Q4
$336K Buy
156,097
+293
+0.2% +$631 ﹤0.01% 3415
2016
Q3
$468K Buy
155,804
+73
+0% +$219 ﹤0.01% 3275
2016
Q2
$396K Sell
155,731
-43,474
-22% -$111K ﹤0.01% 3319
2016
Q1
$586 Buy
199,205
+25,764
+15% +$76 ﹤0.01% 3143
2015
Q4
$1.42M Buy
173,441
+5,607
+3% +$45.9K ﹤0.01% 2697
2015
Q3
$1.2M Buy
167,834
+11,138
+7% +$79.5K ﹤0.01% 2768
2015
Q2
$1.44M Buy
156,696
+7,485
+5% +$68.6K ﹤0.01% 2700
2015
Q1
$1.41M Buy
149,211
+6,513
+5% +$61.5K ﹤0.01% 2669
2014
Q4
$1.39M Buy
142,698
+2,311
+2% +$22.5K ﹤0.01% 2644
2014
Q3
$1.34M Buy
140,387
+147
+0.1% +$1.4K ﹤0.01% 2607
2014
Q2
$1.85M Buy
140,240
+24,599
+21% +$324K ﹤0.01% 2419
2014
Q1
$1.54M Buy
115,641
+29,898
+35% +$398K ﹤0.01% 2503
2013
Q4
$834K Buy
85,743
+1,954
+2% +$19K ﹤0.01% 2828
2013
Q3
$827K Buy
83,789
+12,929
+18% +$128K ﹤0.01% 2700
2013
Q2
$640K Buy
+70,860
New +$640K ﹤0.01% 2731